Alkermes Plc (ALKS)
35.74
+0.42
(+1.19%)
USD |
NASDAQ |
May 07, 14:12
Alkermes SG&A Expense (TTM) : 529.82M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amarin Corp. Plc | 92.35M |
| Assertio Holdings, Inc. | 51.69M |
| Jazz Pharmaceuticals Plc | 1.295B |
| Xenon Pharmaceuticals, Inc. | 79.63M |
| Tyra Biosciences, Inc. | 29.83M |